We are live on ! Find out more
CATX icon

Perspective Therapeutics
CATX

105 hedge funds and large institutions have $385M invested in Perspective Therapeutics in 2024 Q2 according to their latest regulatory filings, with 52 funds opening new positions, 33 increasing their positions, 16 reducing their positions, and 48 closing their positions.

New
Increased
Maintained
Reduced
Closed

106% more repeat investments, than reductions

Existing positions increased: 33 | Existing positions reduced: 16

52.32% more ownership

Funds ownership: 5.01% → 57.32% (+52%)

30% more capital invested

Capital invested by funds: $296M → $385M (+$88.9M)

2% more funds holding

Funds holding: 103 → 105 (+2)

8% more first-time investments, than exits

New positions opened: 52 | Existing positions closed: 48

50% less funds holding in top 10

Funds holding in top 10: 2 → 1 (-1)

Holders
105
Holders Change
+2
Holders Change %
+1.94%
% of All Funds
1.52%
Holding in Top 10
1
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-50%
% of All Funds
0.01%
New
52
Increased
33
Reduced
16
Closed
48
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
Janus Henderson Group
Janus Henderson Group
United Kingdom
+$45.3M
2
APM
Avidity Partners Management
Texas
+$43.9M
3
BlackRock
BlackRock
New York
+$39M
4
CC
Commodore Capital
New York
+$36.9M
5
Vanguard Group
Vanguard Group
Pennsylvania
+$16.5M

Top Sellers

Rank Fund Capital Flow
1
Point72 Asset Management
Point72 Asset Management
Connecticut
-$16.5M
2
HBT
Hills Bank & Trust
Iowa
-$12.3M
3
LCM
Laurion Capital Management
New York
-$10.6M
4
Citadel Advisors
Citadel Advisors
Florida
-$9.41M
5
Marshall Wace
Marshall Wace
United Kingdom
-$8.87M
Name Holding Trade Value Shares
Change 		Change in
Stake
SCM
26
Silverarc Capital Management
Massachusetts
$2.59M -$7.96M -550,802 -68%
Millennium Management
27
Millennium Management
New York
$2.46M -$4.81M -332,915 -57%
DCM
28
DAFNA Capital Management
California
$2.31M -$1.14M -78,730 -25%
Point72 Asset Management
29
Point72 Asset Management
Connecticut
$2.02M -$16.5M -1,142,754 -85%
ACM
30
Altium Capital Management
New York
$1.91M +$1.99M +137,884 +257%
WP
31
WealthPLAN Partners
Nebraska
$1.69M +$2.46M +169,963 New
Morgan Stanley
32
Morgan Stanley
New York
$1.51M +$1.08M +74,460 +96%
ACM
33
Atika Capital Management
New York
$1.42M +$2.06M +142,499 New
HighTower Advisors
34
HighTower Advisors
Illinois
$1.41M +$116K +8,012 +6%
Northern Trust
35
Northern Trust
Illinois
$1.37M +$771K +53,310 +63%
Bank of New York Mellon
36
Bank of New York Mellon
New York
$1.37M +$1.92M +132,896 +3,040%
Charles Schwab
37
Charles Schwab
California
$1.34M +$1.61M +111,275 +474%
Fidelity Investments
38
Fidelity Investments
Massachusetts
$1.34M +$1.94M +134,430 New
SI
39
Sofinnova Investments
California
$1.32M +$1.29M +89,078 +207%
HS
40
HighVista Strategies
Massachusetts
$1.13M +$1.64M +113,550 New
SCM
41
Sandler Capital Management
New York
$1.06M +$1.54M +106,697 New
OCM
42
Osterweis Capital Management
California
$910K -$480K -33,200 -27%
SCM
43
Superstring Capital Management
New York
$874K +$1.27M +87,638 New
UOC
44
UBS O'Connor
Illinois
$848K +$1.23M +85,013 New
WG
45
Winton Group
United Kingdom
$841K +$1.22M +84,363 New
Qube Research & Technologies (QRT)
46
Qube Research & Technologies (QRT)
United Kingdom
$831K +$849K +58,722 +238%
AA
47
AlphaCentric Advisors
Puerto Rico
$818K -$1.35M -93,676 -53%
Jane Street
48
Jane Street
New York
$784K +$1.04M +71,954 +1,073%
PIC
49
Portland Investment Counsel
Ontario, Canada
$698K +$517K +35,746 +104%
ACM
50
ADAR1 Capital Management
Texas
$698K +$33.4K +2,312 +3%
1
2
3 4 5

CATX Hedge Fund Activity: Q2 2024 in Review

105 of the 6,924 institutional investors tracked by Wall St. Rank reported a position in Perspective Therapeutics (CATX) for Q2 2024, worth a combined $385M — up 30% from $296M a quarter earlier.

Buyers outnumbered sellers: 52 funds opened new CATX positions and 48 closed out — a net gain of 4 holders — while 33 added to existing stakes and 16 trimmed.

The largest buyer was Janus Henderson Group, adding an estimated $45.3M. The largest seller was Point72 Asset Management, cutting an estimated $16.5M.

  • 105 institutional investors held Perspective Therapeutics (CATX) as of Q2 2024, up from 103 in Q1 2024.
  • Funds reported $385M of Perspective Therapeutics stock for Q2 2024, up 30% quarter-over-quarter.
  • 52 funds opened new Perspective Therapeutics positions in Q2 2024 and 48 closed out, a net change of +4 holders.
  • The largest Perspective Therapeutics buyer in Q2 2024 was Janus Henderson Group, an estimated $45.3M added.
  • The largest Perspective Therapeutics seller in Q2 2024 was Point72 Asset Management, an estimated $16.5M sold.

Based on aggregated 13F filings for Q2 2024.